Published in Cancer Weekly, April 8th, 2008
"Targeting human primary AML cells with Aur-A kinase inhibitory VX-680 led to apoptotic cell death...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.